He X, Liu J, Zhou Y, Zhao S, Chen Z, Xu Z
Cell Death Differ. 2025; .
PMID: 39972059
DOI: 10.1038/s41418-025-01464-0.
Yu P, Xiao L, Hu K, Ling J, Chen Y, Liang R
Sci Rep. 2025; 15(1):5364.
PMID: 39948103
PMC: 11825851.
DOI: 10.1038/s41598-025-87982-w.
Cheng Y, Chen X, Feng L, Yang Z, Xiao L, Xiang B
Cell Discov. 2025; 11(1):1.
PMID: 39870619
PMC: 11772884.
DOI: 10.1038/s41421-024-00747-z.
Liang J, Vitale T, Zhang X, Jackson T, Yu D, Jedrychowski M
Nat Cancer. 2025; 6(2):323-337.
PMID: 39824999
DOI: 10.1038/s43018-024-00895-x.
Chen Y, Chen A, Hong R, Huang B, Pirooznia M
Sci Rep. 2024; 14(1):31382.
PMID: 39733163
PMC: 11682295.
DOI: 10.1038/s41598-024-82903-9.
A Neutrophil Extracellular Traps-Related Signature Predicts Clinical Outcomes and Identifies Immune Landscape in Ovarian Cancer.
Zhang Y, Wang C, Cheng S, Xu Y, Gu S, Zhao Y
J Cell Mol Med. 2024; 28(24):e70302.
PMID: 39730971
PMC: 11680186.
DOI: 10.1111/jcmm.70302.
Research on the influence of radiotherapy-related genes on immune infiltration, immunotherapy response and prognosis in melanoma based on multi-omics.
Shi Y, Zhao W, Ding Y, Ge X, Ju M
Front Immunol. 2024; 15:1467098.
PMID: 39687627
PMC: 11647020.
DOI: 10.3389/fimmu.2024.1467098.
Multi-omics profiling highlights karyopherin subunit alpha 2 as a promising biomarker for prognosis and immunotherapy respond in pediatric and adult adrenocortical carcinoma.
Chen Y, Fang S, Zhong C, Mo S, Shi Y, Ling X
Ann Med. 2024; 56(1):2397092.
PMID: 39624961
PMC: 11616749.
DOI: 10.1080/07853890.2024.2397092.
Proteomic and transcriptomic analyses identify apo-transcobalamin-II as a biomarker of overall survival in osteosarcoma.
Lacinski R, Dziadowicz S, Roth C, Ma L, Melemai V, Fitzpatrick B
Front Oncol. 2024; 14:1417459.
PMID: 39493449
PMC: 11527601.
DOI: 10.3389/fonc.2024.1417459.
Epigenetic modification of Castor zinc finger 1 (CASZ1) is associated with tumor microenvironments and prognosis of clear cell renal cell carcinoma.
Li F, Liang J, Wei X
Int J Surg. 2024; 111(1):988-997.
PMID: 39235847
PMC: 11745609.
DOI: 10.1097/JS9.0000000000002070.
Tumor-intrinsic CDC42BPB confers resistance to anti-PD-1 immune checkpoint blockade in breast cancer.
Deshpande R, Wu K, Wu S, Tyagi A, Smith E, Hunting J
Mol Ther. 2024; 32(10):3669-3682.
PMID: 39086134
PMC: 11489557.
DOI: 10.1016/j.ymthe.2024.07.021.
Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response in mice and humans.
Skelly D, Graham J, Cheng M, Furuta M, Walter A, Stoklasek T
bioRxiv. 2024; .
PMID: 39071392
PMC: 11275897.
DOI: 10.1101/2024.07.11.603136.
The Epigenetic Modifiers HDAC2 and HDAC7 Inversely Associate with Cancer Stemness and Immunity in Solid Tumors.
Maciejewski K, Giers M, Oleksiewicz U, Czerwinska P
Int J Mol Sci. 2024; 25(14).
PMID: 39063083
PMC: 11277355.
DOI: 10.3390/ijms25147841.
Identification and validation of immune-related gene signature models for predicting prognosis and immunotherapy response in hepatocellular carcinoma.
Liu Z, Yang L, Liu C, Wang Z, Xu W, Lu J
Front Immunol. 2024; 15:1371829.
PMID: 38933262
PMC: 11199539.
DOI: 10.3389/fimmu.2024.1371829.
Multi omics analysis of mitophagy subtypes and integration of machine learning for predicting immunotherapy responses in head and neck squamous cell carcinoma.
Liu J, Li H, Dong Q, Liang Z
Aging (Albany NY). 2024; 16(12):10579-10614.
PMID: 38913914
PMC: 11236326.
DOI: 10.18632/aging.205964.
CanCellVar: A database for single-cell variants map in human cancer.
Yang C, Liu Y, Lv C, Xu M, Xu K, Shi J
Am J Hum Genet. 2024; 111(7):1420-1430.
PMID: 38838674
PMC: 11267512.
DOI: 10.1016/j.ajhg.2024.05.014.
Immunoreactive Microenvironment Modulator GBP5 Suppresses Ovarian Cancer Progression by Inducing Canonical Pyroptosis.
Zou C, Shen J, Xu F, Ye Y, Wu Y, Xu S
J Cancer. 2024; 15(11):3510-3530.
PMID: 38817865
PMC: 11134437.
DOI: 10.7150/jca.94616.
Multiomics Analysis of Disulfidptosis Patterns and Integrated Machine Learning to Predict Immunotherapy Response in Lung Adenocarcinoma.
Liu J, Li H, Zhang N, Dong Q, Liang Z
Curr Med Chem. 2024; 31(25):4034-4055.
PMID: 38685772
DOI: 10.2174/0109298673313281240425050032.
High expression of SLC27A2 predicts unfavorable prognosis and promotes inhibitory immune infiltration in acute lymphoblastic leukemia.
Lu L, Li J, Zheng Y, Luo L, Huang Y, Hu J
Transl Oncol. 2024; 45:101952.
PMID: 38640787
PMC: 11053221.
DOI: 10.1016/j.tranon.2024.101952.
Exploring a specialized programmed-cell death patterns to predict the prognosis and sensitivity of immunotherapy in cutaneous melanoma via machine learning.
Xiao L, He R, Hu K, Song G, Han S, Lin J
Apoptosis. 2024; 29(7-8):1070-1089.
PMID: 38615305
DOI: 10.1007/s10495-024-01960-7.